These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11872878)

  • 1. Immune reconstitution eosinophilia due to schistosomiasis.
    Fernando R; Miller R
    Sex Transm Infect; 2002 Feb; 78(1):76. PubMed ID: 11872878
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis.
    Gaube G; De Castro N; Gueguen A; Lascoux C; Zagdanski AM; Alanio A; Molina JM
    Med Mal Infect; 2016 May; 46(3):154-6. PubMed ID: 26774857
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.
    Yazaki H; Kikuchi Y; Oka S
    Jpn J Infect Dis; 2001 Dec; 54(6):246-7. PubMed ID: 11862010
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
    Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK;
    JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continuing evolution of HIV therapy.
    Boyle BA
    AIDS Read; 2003 Dec; 13(12):576-8, 582. PubMed ID: 14959692
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement of anemia induced by parvovirus B19 in a patient with AIDS after combined antiretroviral therapy.
    Scapellato PG; Palumbo AM; Del Valle S
    Mayo Clin Proc; 2000 Feb; 75(2):215-6. PubMed ID: 10683664
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.
    van Leth F; Hall DB; Lange JM; Reiss P
    HIV Med; 2006 Sep; 7(6):347-50. PubMed ID: 16903977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.
    Havlir DV; Koelsch KK; Strain MC; Margot N; Lu B; Ignacio CC; Miller MD; Wong JK;
    J Infect Dis; 2005 Apr; 191(7):1164-8. PubMed ID: 15747253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral rounds. A very discordant response.
    Henry K; Jenny-Avital E
    AIDS Clin Care; 2002 Jan; 14(1):4-5, 8. PubMed ID: 11802628
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.
    Behrens GM; Meyer D; Stoll M; Schmidt RE
    Immunobiology; 2000 Aug; 202(2):186-93. PubMed ID: 10993293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsules.
    Portsmouth SD; Osorio J; McCormick K; Gazzard BG; Moyle GJ
    HIV Med; 2005 May; 6(3):185-90. PubMed ID: 15876285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral chemotherapy.
    Saag MS; Schooley RT
    Curr Clin Top Infect Dis; 1998; 18():154-79. PubMed ID: 9779354
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune reconstitution inflammatory syndrome following cryptosporidial cholangitis.
    Beauséjour Y; Fortin C; Ghannoum M; Lavergne V
    AIDS; 2011 Sep; 25(14):1801-3. PubMed ID: 21876390
    [No Abstract]   [Full Text] [Related]  

  • 15. An open-label trial of stavudine, lamivudine and efavirenz in the treatment of HIV-positive, treatment-naive patients, and implications for clinical practice.
    Elion R; Green L; Cohen C; Green S; Baird I; Schrader S; Ward D
    Antivir Ther; 1999; 4 Suppl 3():89-91. PubMed ID: 16021878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment in the Northern Cape.
    Jooste JP; Van Zyl AJ; Baker A; Crawford W; Jassen A
    S Afr Med J; 2005 Nov; 95(11):812. PubMed ID: 16344865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].
    Andonegui Navarro J; Aldamiz-Etxebarría M
    Arch Soc Esp Oftalmol; 2002 Sep; 77(9):515-7. PubMed ID: 12221545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cough induced by abacavir apart from a context of hypersensitivity.
    Peyrière H; Mauboussin JM; Arnaud A; Rouanet I; Vincent D
    Allerg Immunol (Paris); 2002 Dec; 34(10):359-60. PubMed ID: 12575618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
    Birlie B; Braekers R; Awoke T; Kasim A; Shkedy Z
    BMC Infect Dis; 2017 Jun; 17(1):453. PubMed ID: 28655306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
    AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.